Article
Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis.
Proceedings of the National Academy of Sciences of the United States of America - 15 Aug 2000
DeBarber A E, Mdluli K, Bosman M, Bekker L G, Barry C E
Abstract excerpt
Ethionamide (ETA) is an important component of second-line therapy for the treatment of multidrug-resistant tuberculosis. Synthesis of radiolabeled ETA and an examination of drug metabolites formed by whole cells of Mycobacterium tuberculosis (MTb) have allowed us to demonstrate that ETA is activated by S-oxidation before interacting with its cellular target. ETA is metabolized by MTb to a 4-pyridylmethanol...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
